Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermittent Androgen Deprivation in Patients With Stage D2 Prostate Cancer, Phase III

NCT00002651 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT00002651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermittent Androgen Deprivation in Patients With Stage D2 Prostate Cancer, Phase III
Lead sponsor
SWOG Cancer Research Network
Phase
Phase 3
Overall status
Completed
Start date
May 31, 1995
Completion date
June 30, 2013
Enrollment
3,040 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer